SCHEDULE 13G

Company

Esperion Therapeutics, Inc.

Filed

August 23, 2022

Accession Number

0000899140-22-000655

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →